Table 2.
Hazard ratio | 95% CI | P-value | |
---|---|---|---|
All cases | |||
Confirmed TB | Reference | ||
Empirically treated TB | 2·28 | 1·97–2·64 | <0·001 |
Year of starting treatment | 0·89 | 0·85–0·93 | <0·001 |
Female | Reference | ||
Male | 1·10 | 0·95–1·28 | 0·12 |
HIV negative | Reference | ||
HIV positive | 2·36 | 1·93–2·88 | <0·001 |
Age in years | 1·02 | 1·01–1·03 | <0·001 |
HIV positive cases only, 2008–2013* | |||
Confirmed TB | Reference | ||
Empirically treated TB | 1·81 | 1·43–2·30 | <0·001 |
Year of starting treatment | 0·86 | 0·79–0·94 | <0·001 |
Female | Reference | ||
Male | 1·20 | 0·94–1·53 | 0·15 |
Age in years | 1·01 | 1·00–1·03 | 0·01 |
Log CD4 | 0·67 | 0·62–0·74 | <0·001 |
2013 is the last year for which CD4 data are available; 1611 individuals had a documented CD4 count with median value of 155 cells/mm3.